PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Clinical trial NCT00911170 · COMPLETED

Trial details

NCT number: NCT00911170
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Colon Cancer Colorectal Cancer Fever Locally Advanced Metastatic Colorectal Cancer Neutropenia Rectal Cancer

Start date: 2009-11-03
Primary completion: 2012-09-17
Enrollment: 847

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.